Bio Green Med Solution Inc
BGMS
4 hedge funds and large institutions have $605K invested in Bio Green Med Solution Inc in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0.13% less ownership
Funds ownership: 9.02% → 8.89% (-0.13%)
20% less funds holding
Funds holding: 5 → 4 (-1)
46% less capital inflows, than outflows
Capital inflows: $35.3K | Capital outflows: $65.3K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$35.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
-$35.3K |
| 2 |
Wedbush Securities
Los Angeles,
California
|
-$12K |
| 3 |
Goldman Sachs
New York
|
-$10K |
| 4 |
Two Sigma Securities
New York
|
-$8K |
BGMS Hedge Fund Activity: Q3 2019 in Review
4 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc (BGMS) for Q3 2019, worth a combined $605K — down 28% from $836K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BGMS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $35.3K. The largest seller was Virtu Financial, exiting entirely with an estimated $35.3K sold.
- 4 institutional investors held Bio Green Med Solution Inc (BGMS) as of Q3 2019, down from 5 in Q2 2019.
- Funds reported $605K of Bio Green Med Solution Inc stock for Q3 2019, down 28% quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc positions in Q3 2019 and 1 closed out, a net change of -1 holder.
- The largest Bio Green Med Solution Inc buyer in Q3 2019 was Renaissance Technologies, an estimated $35.3K added.
- The largest Bio Green Med Solution Inc seller in Q3 2019 was Virtu Financial, an estimated $35.3K sold.
Based on aggregated 13F filings for Q3 2019.